ARTELO BIOSCIENCES, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Artelo Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Artelo Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $55K.
  • Artelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $567K.
  • Artelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $0.000, a 100% decline from 2021.
  • Artelo Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $14.1M, a 612% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $567K +$567K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $0 -$14.1M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $14.1M +$12.1M +612% Sep 1, 2020 Aug 31, 2021 10-K 2023-03-31
2020 $1.98M -$6.4M -76.4% Sep 1, 2019 Aug 31, 2020 10-KT 2022-03-21
2019 $8.38M +$6.99M +503% Sep 1, 2018 Aug 31, 2019 10-K 2020-11-04
2018 $1.39M +$603K +76.8% Sep 1, 2017 Aug 31, 2018 10-K/A 2019-12-18
2017 $785K Sep 1, 2016 Aug 31, 2017 10-K 2018-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.